Sensitive Recovery of Complete SARS-CoV-2 Genomes from Clinical Samples by Use of Swift Biosciences' SARS-CoV-2 Multiplex Amplicon Sequencing Panel

J Clin Microbiol. 2020 Dec 17;59(1):e02226-20. doi: 10.1128/JCM.02226-20. Print 2020 Dec 17.

Authors

Amin Addetia¹, Michelle J Lin¹, Vikas Peddu¹, Pavitra Roychoudhury^{1

2}, Keith R Jerome^{1

2}, Alexander L Greninger^{3

2}

Affiliations

¹ Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
² Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
³ Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA [email protected].

No abstract available

Keywords: SARS-CoV-2; amplicon panel; genome; genome recovery.

Publication types

Evaluation Study
Letter

MeSH terms

COVID-19 / diagnosis
COVID-19 Nucleic Acid Testing / methods*
Gene Library
Genome, Viral / genetics*
Humans
Phylogeny
RNA, Viral / genetics
SARS-CoV-2 / genetics*
Whole Genome Sequencing / methods*

Substances

RNA, Viral